Feasibility and Preliminary Effects of a Structured Resistance Training Program in Children Aged 10-14 Years

April 1, 2026 updated by: Michal Šteffl, Charles University, Czech Republic

Feasibility and Preliminary Effects of a Structured Resistance Training Programme in Children Aged 10-14 Years: A Randomised Controlled Pilot Study

This study is a randomised controlled pilot trial designed to evaluate the feasibility, safety, and preliminary efficacy of a 12-week resistance training intervention in children aged 10-14 years. The study adheres to the CONSORT extension for randomised pilot and feasibility trials and incorporates key elements of the SPIRIT guidelines for clinical trial protocols.

The primary purpose of the study is to assess feasibility-related outcomes and to generate effect size estimates to inform the design of a subsequent fully powered randomised controlled trial (RCT).

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Czech Republic
      • Prague, Czech Republic, Czechia, 16200
        • Faculty of Physical Education and Sport Charles University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children aged 10-14 years
  • Ability to safely participate in supervised resistance training
  • Written informed consent from a parent or legal guardian
  • Assent provided by the child participant
  • Willingness to comply with all study procedures and attend training sessions

Exclusion Criteria:

  • Acute illness at the time of enrolment
  • Recent musculoskeletal injury or immobilisation
  • Chronic cardiovascular, metabolic, or endocrine disorders
  • Use of medications that may affect muscle composition or function
  • Any medical or psychological condition that may compromise safety or adherence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Structured Progressive Resistance Training Program

Participants will complete an 8-week supervised progressive resistance training (PRT) program performed twice weekly. Each ~45-minute session includes a warm-up, whole-body resistance exercises (with emphasis on lower limbs), and a cool-down. Exercises include squat variations, hip hinge movements, unilateral lower-limb exercises, upper-body pushing/pulling, and core stabilization.

Training intensity is guided by a youth-specific RPE scale (5-8), with progressive overload based on individual technique. Sessions are delivered in small groups under qualified supervision to ensure safety and adherence.

The program consists of three phases: familiarisation (weeks 1-2), progressive overload (weeks 3-5), and strength-oriented training (weeks 6-8). Outcomes are assessed pre- and post-intervention.

An 8-week supervised progressive resistance training (PRT) program performed twice weekly in children aged 10-14 years. Each ~45-minute session includes a warm-up, whole-body resistance exercises (with emphasis on lower-limb musculature), and a cool-down. Exercises include squat variations, hip hinge movements, unilateral lower-limb exercises, upper-body pushing and pulling, and core stabilization.

Training intensity is prescribed using a youth-specific rating of perceived exertion (RPE 5-8), with progressive overload applied individually based on proper technique. The program is divided into three phases: familiarisation (weeks 1-2), progressive overload (weeks 3-5), and strength-oriented training (weeks 6-8). Sessions are delivered in small groups under qualified supervision to ensure safety and adherence.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle Quality (Echo Intensity)
Time Frame: Time Frame: Pre-intervention (baseline) and post-intervention (8 weeks)
Ultrasound-derived echo intensity (EI) of the quadriceps femoris (QF) muscle assessed as an indicator of skeletal muscle quality. EI will be derived from longitudinal scans of each QF head and the cross-sectional area (CSAQF) from panoramic mid-thigh images
Time Frame: Pre-intervention (baseline) and post-intervention (8 weeks)
Muscle Strength (Knee Extensor Strength)
Time Frame: Time Frame: Pre-intervention and post-intervention (8 weeks)
Maximum voluntary contraction (MVC) of knee extensors measured using an isokinetic dynamometer.
Time Frame: Pre-intervention and post-intervention (8 weeks)
Feasibility of the Intervention
Time Frame: Throughout the 8-week intervention
Feasibility assessed by recruitment rate, retention rate, and adherence to the training program (percentage of sessions attended and proportion of participants attending ≥80% of sessions).
Throughout the 8-week intervention
Safety of the Intervention
Time Frame: Throughout the 8-week intervention
Safety evaluated by the number, type, and severity of adverse events recorded during training sessions, and the proportion of participants experiencing at least one adverse event.
Throughout the 8-week intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Performance
Time Frame: Pre-intervention and post-intervention (8 weeks)
Functional lower-body performance assessed using the 30-second sit-to-stand test (30STS).
Pre-intervention and post-intervention (8 weeks)
Body Composition
Time Frame: Pre-intervention and post-intervention (8 weeks)
Body composition assessed using dual-energy X-ray absorptiometry (DXA), including lean mass and fat mass parameters.
Pre-intervention and post-intervention (8 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

September 30, 2028

Study Registration Dates

First Submitted

March 26, 2026

First Submitted That Met QC Criteria

April 1, 2026

First Posted (Actual)

April 6, 2026

Study Record Updates

Last Update Posted (Actual)

April 6, 2026

Last Update Submitted That Met QC Criteria

April 1, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • EK 007/2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ultrasonic Diagnosis

Clinical Trials on Progressive Resistance Training Program

Subscribe